Jaime Lee, DPM
Foot & Ankle Surgery · Temple, TXNPI 1407352925
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (48.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Orthofix Medical, Inc. accounts for 72.3% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $8,447 and has fallen 73.3% since, to $2,253 in 2025.
Across 139 payments — averaging $129.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Orthofix Medical, Inc.$13K
- Pylant Medical$2K
- Stryker$1K
- Arthrex$836
- In2bones USA, LLC$540
- Integra Lifesciences Corporation$180
- plus $266 from 5 others
What the payments were for
- Consulting fees$5,25029%
- Travel & lodging$8,66948%
- Food & beverage$3,96722%
- Education$590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Orthofix Medical, Inc. | 91 | $12,981 |
| Pylant Medical | 12 | $1,649 |
| Stryker | 18 | $1,493 |
| Arthrex | 9 | $836 |
| In2bones USA, LLC | 1 | $540 |
| Integra Lifesciences Corporation | 3 | $180 |
| Cerapedics Inc. | 1 | $141 |
| Smith+Nephew | 1 | $69 |
| Biocomposites Inc | 1 | $30 |
| Bioventus LLC | 1 | $13 |
| Paragon 28, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANKLE HINDFOOT NAILING SYSTEM$5,905
- TrueLok$4,392
- TL-HEX TRUELOK HEXAPOD SYSTEM$567
- Quantum Total Ankle$540
- PRIME SERIES$472
- PROstep$268
- CITREFIX$235
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$141
- EASYFUSE$134
- ORTHOLOC 2 LAPIFUSE$134
- 7 X 23MM CITRELOCK IMPLANT$134
- INBONE$104
- HOFFMANN$103
How this compares
$17,944 in reported general payments places this provider in the 80th percentile of 684 foot & ankle surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 23 | $855 |
| Doxycycline Monohydrate | 13 | $314 |
| Terbinafine Hcl | 20 | $217 |
| Ammonium Lactate | 12 | $198 |
| Oxycodone Hcl | 22 | $78 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Temple
- William McGarveyKaty$3.5M
- Eugene CurryDallas$3.1M
- Graham HamiltonEdinburg$2.1M
- Mark DaltonAustin$1.9M
- Kevin VarnerHouston$1.1M
- Paul KimDallas$928K
- Sherman NaglerHouston$602K
- John EarlyDallas$553K
- Michael DowneySouthlake$475K
- Abdul NurudeenHouston$404K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.